Principal Financial Group Inc. Sells 3,647 Shares of DaVita Inc. (NYSE:DVA)

Principal Financial Group Inc. decreased its position in shares of DaVita Inc. (NYSE:DVA) by 5.8% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 59,168 shares of the company’s stock after selling 3,647 shares during the period. Principal Financial Group Inc. owned about 0.07% of DaVita worth $9,699,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently modified their holdings of the company. Ritholtz Wealth Management raised its stake in shares of DaVita by 3.9% in the second quarter. Ritholtz Wealth Management now owns 9,783 shares of the company’s stock worth $1,356,000 after acquiring an additional 371 shares during the last quarter. Convergence Investment Partners LLC lifted its holdings in DaVita by 99.2% during the 2nd quarter. Convergence Investment Partners LLC now owns 5,472 shares of the company’s stock worth $758,000 after buying an additional 2,725 shares in the last quarter. TD Asset Management Inc boosted its position in DaVita by 2.0% in the 2nd quarter. TD Asset Management Inc now owns 14,046 shares of the company’s stock valued at $1,946,000 after buying an additional 278 shares during the last quarter. Range Financial Group LLC increased its stake in shares of DaVita by 28.0% in the 2nd quarter. Range Financial Group LLC now owns 3,773 shares of the company’s stock valued at $523,000 after buying an additional 826 shares during the period. Finally, Chase Investment Counsel Corp bought a new stake in shares of DaVita during the second quarter worth $2,966,000. Institutional investors own 90.12% of the company’s stock.

DaVita Price Performance

DaVita stock opened at $149.79 on Tuesday. The firm has a market capitalization of $12.28 billion, a P/E ratio of 16.16, a PEG ratio of 0.86 and a beta of 0.90. The business has a 50-day moving average of $156.19 and a 200-day moving average of $151.41. The company has a current ratio of 1.37, a quick ratio of 1.33 and a debt-to-equity ratio of 15.78. DaVita Inc. has a 1 year low of $103.40 and a 1 year high of $169.51.

DaVita (NYSE:DVA) last posted its earnings results on Tuesday, October 29th. The company reported $2.59 earnings per share for the quarter, missing the consensus estimate of $2.76 by ($0.17). DaVita had a return on equity of 88.18% and a net margin of 6.53%. The firm had revenue of $3.26 billion during the quarter, compared to analyst estimates of $3.25 billion. During the same quarter last year, the business posted $2.85 earnings per share. The company’s revenue for the quarter was up 4.6% on a year-over-year basis. On average, equities analysts anticipate that DaVita Inc. will post 9.71 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of analysts recently commented on DVA shares. Truist Financial lifted their price objective on DaVita from $165.00 to $175.00 and gave the stock a “hold” rating in a research report on Monday, October 7th. Barclays boosted their price target on shares of DaVita from $150.00 to $164.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 31st. One research analyst has rated the stock with a sell rating, three have issued a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $161.80.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.